Shazeeb, Mohammed Salman http://orcid.org/0000-0002-3175-8098
King, Robert M.
Brooks, Olivia W.
Puri, Ajit S.
Henninger, Nils
Boltze, Johannes
Gounis, Matthew J.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (K08NS091499)
Article History
Received: 17 July 2019
Revised: 19 August 2019
Accepted: 21 August 2019
First Online: 3 September 2019
Compliance with Ethical Standards
:
: Dr. Henninger is supported by K08NS091499 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Dr. Henninger serves on the advisory board of Omniox, Inc. and serves as consultant to Astrocyte Pharmaceuticals, Inc. Dr. Gounis has been a consultant on a fee-per-hour basis for Cerenovus, Imperative Care, Mivi Neurosciences, Phenox, Route 92 Medical, Stryker Neurovascular; holds stock in Imperative Care and Neurogami; and has received research support from the NIH, the United States–Israel Binational Science Foundation, Anaconda, Cerenovus, Ceretrieve, Cook Medical, Gentuity, Imperative Care, InNeuroCo, Magneto, Microvention, Medtronic Neurovascular, MIVI Neurosciences, Neuravi, Neurogami, Philips Healthcare, Rapid Medical, Route 92 Medical, Stryker Neurovascular, Syntheon, and the Wyss Institute. All authors declare that they have no potential conflicts of interest in regard to the research, authorship, and publication of this paper.
: All animal research procedures were performed as approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Massachusetts Medical School (Worcester, MA, USA). This article does not contain any studies with human participants performed by any of the authors.